Given their potential to treat rare, inherited diseases, as
well as those previously deemed incurable, the field of gene therapy has gained
significant traction in the last few years
Roots
Analysis
is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.
The report features an extensive study of the current
market landscape of gene therapies, primarily focusing on gene
augmentation-based therapies, oncolytic viral therapies, immunotherapies and
gene editing therapies. The study also features an elaborate discussion on the
future potential of this evolving market. In addition to other elements, the
study includes:
§
A detailed review of the overall market landscape of gene
therapies and gene editing therapies, including information on phase of
development of pipeline candidates, key therapeutic areas, target disease
indication(s), type of vector used, type of gene, type of modification, type of
gene therapy, route of administration and special drug designation(s) awarded (if
any).
§
A detailed review of the players engaged in the development
of gene therapies.
§
An elaborate discussion on the various types of viral and
non-viral vectors.
§
A discussion on the regulatory landscape related to gene
therapies across various geographies, namely North America, Europe and
Asia-Pacific.
§
Detailed profiles of marketed and late stage (phase II/III
and above) gene therapies.
§
An elaborate discussion on the various commercialization
strategies that can be adopted by drug developers across different stages of
therapy development.
§
A review of the various emerging technologies and therapy
development platforms that are being used to design and manufacture gene
therapies.
§
An in-depth analysis of various patents that have been
filed / granted related to gene therapies and gene editing therapies, since
2016.
§
A detailed analysis of the various mergers and acquisitions
that have taken place within this domain, during the period 2015-2020.
§
An analysis of the investments made at various stages of
development in companies that are focused in this area, between 2015-2020.
§
A detailed geographical clinical trial analysis of
completed, ongoing and planned studies of numerous gene therapies.
§
An analysis of the various factors that are likely to
influence the pricing of gene therapies.
§
An analysis of the big biopharma players engaged in this
domain.
§
An informed estimate of the annual demand for gene
therapies.
§
A case study on the prevalent and emerging trends related
to vector manufacturing.
§
A discussion on the various operating models adopted by
gene therapy developers for supply chain management.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Gene augmentation
§
Oncolytic therapy
§
Immunotherapy
§
Others
§
Ex
vivo
§ In
vivo
§
Adeno associated virus
§
Adenovirus
§
Herpes simplex virus
§
Lentivirus
§
Plasmid DNA
§
Retrovirus
§
Others
§
Autoimmune disorders
§
Cardiovascular diseases
§
Dermatological disorders
§
Genetic disorders
§
Hematological disorders
§
Metabolic disorders
§
Muscle-related diseases
§
Oncological disorders
§
Ophthalmic diseases
§
Others
§
Intraarticular
§
Intracerebellar
§
Intradermal
§
Intramuscular
§
Intratumoral
§
Intravenous
§
Intravesical
§
Intravitreal
§
Subretinal
§
Others
§
North America
§
Europe
§
Asia-Pacific
Key
companies covered in the report
§
Abeona Therapeutics
§
Advantagene
§
Biogen
§
bluebird bio
§
Castle Creek
Biosciences
§
CG Oncology
§
FerGene
§
Freeline Therapeutics
§
Gradalis
§
Helixmith
§
Inovio
Pharmaceuticals
§
Kolon TissueGene
§
Krystal Biotech
§
Lysogene
§
Neurophth
Therapeutics
§
OncoSec
Immunotherapies
§
Orchard Therapeutics
§
Pfizer
§
Sangamo Therapeutics
§
Spark Therapeutics
§
uniQure Biopharma
§
VBL Therapeutics
For
more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html
Other Recent Offerings
1. Viral
Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th
Edition), 2021-2030
2. Global
T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030
3. Oncolytic
Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive
Insights, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the bio-pharmaceutical
industry. The in-depth research, analysis and insights are driven by an
experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
